The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Progressive histological damage in liver allografts following pediatric liver transplantation
Open accessAbstract
The long-term histological outcome after pediatric liver transplantation (OLT) is not yet fully understood. De novo autoimmune hepatitis, consisting of histological chronic hepatitis associated with autoantibody formation and allograft dysfunction, is increasingly recognized as an important complication of liver transplantation, particularly in the pediatric population. In this study, 158 asymptomatic children with 5-year graft survival underwent protocol liver biopsies (113, 135, and 64 at 1, 5, and 10 years after OLT, respectively). Histological changes were correlated with clinical, biochemical, and serological findings. All patients received cyclosporine A as primary immunosuppression with withdrawal of corticosteroids at 3 months post OLT. Normal or near-normal histology was reported in 77 of 113 (68%), 61 of 135 (45%), and 20 of 64 (31%) at 1, 5, and 10 years, respectively. The commonest histological abnormality was chronic hepatitis (CH), the incidence of which increased with time [25/113 (22%), 58/135 (43%), and 41/64 (64%) at 1, 5, and 10 years, respectively) ( P < .0001)]. The incidence of fibrosis associated with CH increased with time [13/25 (52%), 47/58 (81%), and 37/41 (91%) at 1, 5, and 10 years, respectively) ( P < .0001)]. The severity of fibrosis associated with CH also increased with time, such that by 10 years 15% had progressed to cirrhosis. Aspartate aminotransferase (AST) levels were slightly elevated in children with CH (median levels 52 IU/L, 63 IU/L, and 48 IU/L at 1, 5, and 10 years, respectively), but this did not reach statistical significance compared with those with normal histology. On multivariate analysis, the only factor predictive of chronic hepatitis was autoantibody positivity (present in 13% and 10% of children with normal biopsies at 5 and 10 years, respectively, and 72% and 80% of those with CH at 5 and 10 years, respectively) ( P < .0001). Four children with CH and autoantibodies, who also had raised immunoglobulin G (IgG) levels and AST greater than 1.5× normal fulfilled the diagnostic criteria for de novo autoimmune hepatitis (AIH). Another two were found to be hepatitis C positive. No definite cause for CH could be identified in the other cases. In conclusion , chronic hepatitis is a common finding in children after liver transplantation and is associated with a high risk of developing progressive fibrosis, leading to cirrhosis. Standard liver biochemical tests cannot be relied on either in the diagnosis or in the monitoring of progress of chronic allograft hepatitis. In contrast, the presence of autoantibodies is strongly associated with the presence of CH. The cause of chronic hepatitis in transplanted allografts is uncertain but may be immune mediated, representing a hepatitic form of chronic rejection. (Hepatology 2006;43:1109–1117.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De-novo autoimmune hepatitis after liver transplantation
Kerkar, N., Hadzic, N., Davies, E. T., Portmann, B., Donaldson, P. T., Rela, M., Heaton, N. D., Vergani, D., & Mieli-Vergani, G. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06478-7 · Cited by 413
Experience With Liver And Kidney Allografts From Non-Heart-Beating Donors
Casavilla, A., Ramirez, C., Shapiro, R., Nghiem, D., Miracle, K., Bronsther, O., Randhawa, P., Broznick, B., Fung, J. J., & Starzl, T. (1995) · Transplantation · doi:10.1097/00007890-199501000-00008 · Cited by 387
Fouquet, V., Alves, A., Branchereau, S., Grabar, S., Debray, D., Jacquemin, E., Devictor, D., Durand, P., Baujard, C., Fabre, M., et al. (2005) · Liver Transplantation · doi:10.1002/lt.20358 · Cited by 221
Hubscher, S. G., Elias, E., Buckels, J. A. C., Mayer, A. D., McMaster, P., & Neuberger, J. M. (1993) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80244-2 · Cited by 181
Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults
Heneghan, M. A., Portmann, B. C., Norris, S. M., Williams, R. L., Muiesan, P., Rela, M., Heaton, N. D., & O’Grady, J. G. (2001) · Hepatology · doi:10.1053/jhep.2001.26756 · Cited by 156
Neuberger, J., Gunson, B., Hubscher, S., & Nightingale, P. (2004) · Liver Transplantation · doi:10.1002/lt.20123 · Cited by 155
Pappo, O., Ramos, H., Starzl, T. E., Fung, J. J., & Demetris, A. J. (1995) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199502000-00008 · Cited by 138
All Liver Recipients Benefit From the Protocol 10–Year Liver Biopsies
Sebagh, M., Rifai, K., Féray, C., Yılmaz, F., Falissard, B., Roche, B., Bismuth, H., Samuel, D., & REYNES, M. (2003) · Hepatology · doi:10.1053/jhep.2003.50231 · Cited by 136
DE NOVO HEPATITIS WITH AUTOIMMUNE ANTIBODIES AND ATYPICAL HISTOLOGY
Gupta, P. K., Hart, J. A. L., Millis, J. M., Cronin, D. C., & Brady, L. M. (2001) · Transplantation · doi:10.1097/00007890-200103150-00016 · Cited by 120
Graft and Systemic Disease in Long–Term Survivors of Liver Transplantation
Slapak, G., Saxena, R., Portmann, B. C., Gane, E. J., Devlin, J., Calne, R. Y., & Williams, R. L. (1997) · Hepatology · doi:10.1002/hep.510250136 · Cited by 118
Cited by
Demetris, A. J., Bellamy, C., Hübscher, S. G., O’Leary, J., Randhawa, P. S., Feng, S., Neil, D., Colvin, R. B., McCaughan, G., Fung, J. J., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13909 · Cited by 650
Self-citationLiver biopsy interpretation for causes of late liver allograft dysfunction
(2006) · Hepatology · doi:10.1002/hep.21280 · Cited by 359
Benítez, C., Londoño, M.-C., Miquel, R., Manzia, T.-M., Abraldes, J. G., Lozano, J.-J., Martínez-Llordella, M., López, M., Angelico, R., Bohne, F., et al. (2013) · Hepatology · doi:10.1002/hep.26426 · Cited by 318
Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury
Liu, Y., Lu, T., Zhang, C., Xu, J., Xue, Z., Busuttil, R. W., Xu, N., Xia, Q., Kupiec-Weglinski, J. W., & Ji, H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.05.029 · Cited by 278
Ng, V. L., Alonso, E. M., Bucuvalas, J. C., Cohen, G., Limbers, C. A., Varni, J. W., Mazariegos, G., Magee, J., McDiarmid, S. V., & Anand, R. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.10.038 · Cited by 258
Metadata
- Authors
- Evans, H. M., Kelly, D. A., McKiernan, P. J., & Hübscher, S.
- Venue
- Hepatology
- Published
- 2006-05
- Volume
- 43
- Issue
- 5
- Pages
- 1109-1117
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2064656758
- Cited by
- 304
- References
- 27
- FWCI
- 14.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Progressive histological damage in liver allografts following pediatric liver transplantation. https://app.cochat.ai/papers/10.1002/hep.21152
- The paper
- Evans, H. M., Kelly, D. A., McKiernan, P. J., & Hübscher, S. (2006). Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology. https://doi.org/10.1002/hep.21152
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.